# Elicio Therapeutics, Inc.: Form 8-K, filed Aug 30, 2024

- Company: [Elicio Therapeutics, Inc.](/companies/eltx.md) (CIK 1601485)
- Form: 8-K
- Filed: 2024-08-30
- Accepted by EDGAR: Aug 30, 2024, 08:30 ET
- Period: 2024-08-27
- Accession: 0001140361-24-039592
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1601485/000114036124039592/ef20035237_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1601485/000114036124039592/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1601485/000114036124039592/ef20035237_8k.htm

Filed Aug 30, 2024.
Source: SEC EDGAR, the filing index for accession 0001140361-24-039592. Last ingested by Listed: Nov 14, 2026, 18:50 ET. No prices; not investment advice.
